BioTech Medics, Inc. (OTC PINK:BMCS) and its subsidiary Commodity Vault are pleased to announce that the firms have created the architecture for our RWA Tokenization Trading Platform that includes, tokens, various commodities, verified blockchains, white papers, apps, wallets, websites, stocks and strategic partnerships all of these components, and more encompass our ecosystem
Read More
Additional volume orders are expected in the second half of 2024 based upon combat success in operational conditions
The Iron Drone Raider system is a unique, innovative counter-drone system using an autonomous AI-guided interception drone launched from a designated docking station
This direct purchase from a government military customer positions Ondas as a prime defense contractor and Iron Drone as a new, potentially leading solution, for the $1.6 billion counter-drone market
Read MorePrestigious award recognizes women transforming real estate through outstanding leadership and a dedication to excellence, inspiring the next generation of leaders
Read More
After A Successful Outcome of MaxClean 756's Test-Pilot and Full Adoption by School District,
Contract Estimated to be up to a Potential $67 Million Dollars [1] Covering 225 Facilities
Comprising of More than 28 Million Square Feet of Total Space [2].
Read MoreA lawsuit is pending for certain investors in shares of The Scotts Miracle-Gro Company. Investors who purchased shares of The Scotts Miracle-Gro Company (NYSE:SMG) prior to November 2021 and continue to hold any of those NYSE: SMG shares have also certain options and should contact the Shareholders Foundation.
Read MoreWebcast on Tuesday, July 23rd at 8:30 AM Eastern will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer therapy-related diarrhea (CTD) and oral mucositis; Click here to register for webcast
Jaguar expands Make Cancer Less Shitty (MCLS) patient advocacy program to incorporate select group of MCLS Ambassadors - cancer survivors who understand the realities of cancer and are no longer willing to accept debilitating side effects of cancer treatments as an acceptable trade-off for survival
Cancer patients with diarrhea are 40% more likely to discontinue their therapy; oral mucositis affects up to 40% of patients undergoing chemotherapy and approximately 90% of those receiving chemoradiation for head and neck cancers, with more than one-third of patients discontinuing cancer treatment because of the condition
Read More
